Evidence map›Paper›PMID 26558538›Full record

ReviewInternational journal of clinical practice2016

Predictive factors and clinical biomarkers for treatment in patients with chronic pain caused by osteoarthritis with a central sensitisation component.

A Akinci, M Al Shaker, M H Chang, C W Cheung, A Danilov, H José Dueñas, Y C Kim, R Guillen, W Tassanawipas, T Treuer and 1 more

2 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in International journal of clinical practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05020600 unknown statusnot on this mapstarted 2021, after this paper: background citation

Investigation of the Effect of Initial Central Sensitization Severity on Treatment Response in Patients With Fibromyalgia

TypeobservationalSponsorMarmara UniversityRan2021 to 2024Enrolled40ConditionsCentral Sensitisation, FibromyalgiaArmsDuloxetine, Pregabalin, Amitriptyline
NCT06948903 recruitingnot on this mapstarted 2023, after this paper: background citation

Investigation of the Relationship Between Central Sensitization Symptoms and Cognitive Dysfunction in Patients With Fibromyalgia

TypeobservationalSponsorSultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyRan2023 to 2025Enrolled100ConditionsFibromyalgia, Cognitive Dysfunction, Central SensitisationArmsCentral Sensitization Inventory, The Montreal Cognitive Assessment, Cognitive Symptom Severity Scale-Extended, Fibromyalgia Impact Questionnaire, Numeric rating scale
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Low central sensitisation inventory score is associated with better post-operative outcomes of osteotomy around the knee.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 11 institutions in 11 countries.

A AkinciDepartment of Physical Medicine and Rehabilitation, School of Medicine, University of Hacettepe University, Ankara, Turkey.
M Al ShakerKing Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.
M H ChangTaichung Veterans General Hospital, Taichung, Taiwan.
C W CheungDepartment of Anaesthesiology, Laboratory and Clinical Research Institute for Pain, The University of Hong Kong, Hong Kong, China.
A DanilovI.M. Sechenov First Moscow State Medical University, Moscow, Russia.
H José DueñasEli Lilly and Co, México City, México.
Y C KimSeoul National University School of Medicine, Pain Management Center of the Seoul National University Hospital, Seoul, Korea.
R GuillenPain Clinic, National Cancer Institute, México DF, México.
W TassanawipasDepartment of Orthopaedics, Phramongkutklao Army Hospital, Bangkok, Thailand.
T TreuerEli Lilly and Co, Budapest, Hungary.
Y WangHuashan Hospital, Fudan University, Shanghai, China.
ELI-HU Research and Development Non-Profit · HUEli Lilly (Spain) · ESHacettepe University · TRHuashan Hospital · CNInstituto Nacional de Cancerología · MXKing Faisal Specialist Hospital & Research Centre · SAPhramongkutklao Hospital · THSechenov University · RUSeoul National University Hospital · KRTaichung Veterans General Hospital · TWUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe aim of this non-systematic review was to provide a practical guide for clinicians on the evidence for central sensitisation in chronic osteoarthritis (OA) pain and how this pain mechanism can be addressed in terms of clinical diagnosis, investigation and treatment.

methodsThe authors undertook a non-systematic review of the literature including a MEDLINE search (search terms included central sensitisation, osteoarthritis, osteoarthrosis) for relevant and current clinical studies, systematic reviews and narrative reviews. Case reports, letters to the editor and similar literature sources were excluded. Information was organised to allow a pragmatic approach to the discussion of the evidence and generation of practical recommendations.

resultsThere is good evidence for a role of central sensitisation in chronic OA pain in a subgroup of patients. Clinically, a central sensitisation component in chronic OA pain can be suspected based on characteristic pain features and non-pain features seen in other conditions involving central sensitisation. However, there are currently no diagnostic inventories for central sensitisation specific to OA. Biomarkers may be helpful for confirming the presence of central sensitisation, especially when there is diagnostic uncertainty. Several non-pharmacological and pharmacological treatments may be effective in OA patients with central sensitisation features. Multimodal therapy may be required to achieve control of symptoms. DISCUSSION: Clinicians should be aware of central sensitisation in patients with chronic OA pain, especially in patients presenting with severe pain with unusual features.

Indexed as

Central Nervous System SensitizationBiomarkersChronic PainCombined Modality TherapyFunctional NeuroimagingHumansMagnetic Resonance ImagingNociceptionOsteoarthritisPain MeasurementRisk FactorsBiomarkers

Identifiers

PMID26558538
PMCPMC4738415
OpenAlexW2111097444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.